TWD 30.0
(0.0%)
Year | Total Assets | Total Assets Growth |
---|---|---|
2023 | 1.57 Billion TWD | -8.03% |
2022 | 1.71 Billion TWD | -6.75% |
2021 | 1.83 Billion TWD | -3.22% |
2020 | 1.9 Billion TWD | 0.0% |
2019 | - TWD | 0.0% |
Year | Total Assets | Total Assets Growth |
---|---|---|
2024 Q1 | 1.68 Billion TWD | 6.88% |
2024 Q2 | 1.66 Billion TWD | -0.96% |
2023 Q3 | 1.91 Billion TWD | 16.35% |
2023 Q2 | 1.64 Billion TWD | -2.87% |
2023 FY | 1.57 Billion TWD | -8.03% |
2023 Q1 | 1.69 Billion TWD | 0.0% |
2023 Q4 | 1.57 Billion TWD | -17.57% |
2022 Q4 | - TWD | 0.0% |
Name | Total Assets | Total Assets Difference |
---|---|---|
Allied Biotech Corporation | 2.07 Billion TWD | 24.127% |
GeneFerm Biotechnology Co., Ltd. | 1.17 Billion TWD | -34.198% |
Easywell Biomedicals, Inc. | 1.21 Billion TWD | -29.951% |
TTY Biopharm Company Limited | 9.87 Billion TWD | 84.027% |
Synmosa Biopharma Corporation | 11.72 Billion TWD | 86.551% |
Orient EuroPharma Co., Ltd. | 10.81 Billion TWD | 85.411% |
Center Laboratories, Inc. | 27 Billion TWD | 94.159% |
Tien Liang BioTech Co., Ltd. | 654.03 Million TWD | -141.169% |
Orient Pharma Co., Ltd. | 2.56 Billion TWD | 38.45% |
InnoPharmax Inc. | 524.19 Million TWD | -200.904% |
Johnson Chemical Pharmaceutical Works Co., Ltd. | 1.99 Billion TWD | 20.854% |
DV Biomed Co., Ltd. | 1.81 Billion TWD | 12.982% |
Foresee Pharmaceuticals Co., Ltd. | 1.86 Billion TWD | 15.263% |
Handa Pharmaceuticals, Inc. | 3.03 Billion TWD | 48.066% |
UniPharma Co., Ltd. | 350.07 Million TWD | -350.57% |
Anxo Pharmaceutical Co., Ltd. | 2.21 Billion TWD | 28.904% |
Alar Pharmaceuticals Inc. | 973.2 Million TWD | -62.075% |
Winston Medical Supply Co., Ltd. | 801.77 Million TWD | -96.729% |
Mercury Biopharmaceutical Corporation | 438.07 Million TWD | -260.059% |
Bioray Biotech Co., Ltd | 542.64 Million TWD | -190.672% |
TSH Biopharm Corporation Limited | 1.39 Billion TWD | -12.678% |